PAOG CBD Pharma Development Initiative In Puerto Rico Could Get Boost From COVID-19

"PAOG is currently in discussions in to engage a Contract Research Organization (CRO) in Puerto Rico to advance an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for PAOG's RespRx as a COPD treatment."

091720 PAOG CBD Pharma Development Initi
.
Download • 183KB

Recent Posts

See All

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2020 by Medical and Pharma Insider and FC Global Strategies LLC